Centers for Disease Control and Prevention (CDC): FDA approval for a combined hepatitis A and B vaccine. Morbidity and mortality weekly report, 21.9.2001, 50. vsk, nro 37, s. 806–807. PubMed:11785573ISSN 0149-2195Artikkelin verkkoversio.
Natalie Kash, Michael A. Lee, Ramya Kollipara, Christopher Downing, Jacqueline Guidry, Stephen K. Tyring: Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus. Journal of Clinical Medicine, 3.4.2015, 4. vsk, nro 4, s. 614–633. PubMed:26239350doi:10.3390/jcm4040614ISSN 2077-0383Artikkelin verkkoversio.
Jeffrey D Stanaway, Abraham D Flaxman, Mohsen Naghavi, Christina Fitzmaurice, Theo Vos, Ibrahim Abubakar: The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet, 10.9.2016, 388. vsk, nro 10049, s. 1081–1088. PubMed:27394647doi:10.1016/S0140-6736(16)30579-7ISSN 0140-6736Artikkelin verkkoversio.
Ryan J. Sullivan, Liron Pantanowitz, Corey Casper, Justin Stebbing, Bruce J. Dezube: Epidemiology, pathophysiology and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clinical infectious diseases, 1.11.2008, 47. vsk, nro 9, s. 1209–1215. PubMed:18808357doi:10.1086/592298ISSN 1058-4838Artikkelin verkkoversio.
Michael Melnick, Parish P. Sedghizadeh, Carl M. Allen, Tina Jaskoll: Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Experimental and Molecular Pathology, helmikuu 2012, 92. vsk, nro 1, s. 118–125. PubMed:22101257doi:10.1016/j.yexmp.2011.10.011ISSN 1096-0945Artikkelin verkkoversio.
iiarjournals.org
cgp.iiarjournals.org
Marcia Bellon, Christophe Nicot: Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia. Cancer Genomics & Proteomics, tammikuu 2007, 4. vsk, nro 1, s. 21–25. PubMed:17726237ISSN 1109-6535Artikkelin verkkoversio.
Natalie Kash, Michael A. Lee, Ramya Kollipara, Christopher Downing, Jacqueline Guidry, Stephen K. Tyring: Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus. Journal of Clinical Medicine, 3.4.2015, 4. vsk, nro 4, s. 614–633. PubMed:26239350doi:10.3390/jcm4040614ISSN 2077-0383Artikkelin verkkoversio.
Jeffrey D Stanaway, Abraham D Flaxman, Mohsen Naghavi, Christina Fitzmaurice, Theo Vos, Ibrahim Abubakar: The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet, 10.9.2016, 388. vsk, nro 10049, s. 1081–1088. PubMed:27394647doi:10.1016/S0140-6736(16)30579-7ISSN 0140-6736Artikkelin verkkoversio.
Centers for Disease Control and Prevention (CDC): FDA approval for a combined hepatitis A and B vaccine. Morbidity and mortality weekly report, 21.9.2001, 50. vsk, nro 37, s. 806–807. PubMed:11785573ISSN 0149-2195Artikkelin verkkoversio.
Jianming Hu, Laurie Ludgate: HIV-HBV and HIV-HCV coinfection and liver cancer development. Cancer Treatment and Research, 2007, nro 133, s. 241–252. PubMed:17672044ISSN 0927-3042
Ryan J. Sullivan, Liron Pantanowitz, Corey Casper, Justin Stebbing, Bruce J. Dezube: Epidemiology, pathophysiology and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clinical infectious diseases, 1.11.2008, 47. vsk, nro 9, s. 1209–1215. PubMed:18808357doi:10.1086/592298ISSN 1058-4838Artikkelin verkkoversio.
Marcia Bellon, Christophe Nicot: Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia. Cancer Genomics & Proteomics, tammikuu 2007, 4. vsk, nro 1, s. 21–25. PubMed:17726237ISSN 1109-6535Artikkelin verkkoversio.
Michael Melnick, Parish P. Sedghizadeh, Carl M. Allen, Tina Jaskoll: Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Experimental and Molecular Pathology, helmikuu 2012, 92. vsk, nro 1, s. 118–125. PubMed:22101257doi:10.1016/j.yexmp.2011.10.011ISSN 1096-0945Artikkelin verkkoversio.
ncbi.nlm.nih.gov
Natalie Kash, Michael A. Lee, Ramya Kollipara, Christopher Downing, Jacqueline Guidry, Stephen K. Tyring: Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus. Journal of Clinical Medicine, 3.4.2015, 4. vsk, nro 4, s. 614–633. PubMed:26239350doi:10.3390/jcm4040614ISSN 2077-0383Artikkelin verkkoversio.
Jeffrey D Stanaway, Abraham D Flaxman, Mohsen Naghavi, Christina Fitzmaurice, Theo Vos, Ibrahim Abubakar: The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet, 10.9.2016, 388. vsk, nro 10049, s. 1081–1088. PubMed:27394647doi:10.1016/S0140-6736(16)30579-7ISSN 0140-6736Artikkelin verkkoversio.
Ryan J. Sullivan, Liron Pantanowitz, Corey Casper, Justin Stebbing, Bruce J. Dezube: Epidemiology, pathophysiology and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clinical infectious diseases, 1.11.2008, 47. vsk, nro 9, s. 1209–1215. PubMed:18808357doi:10.1086/592298ISSN 1058-4838Artikkelin verkkoversio.
Michael Melnick, Parish P. Sedghizadeh, Carl M. Allen, Tina Jaskoll: Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Experimental and Molecular Pathology, helmikuu 2012, 92. vsk, nro 1, s. 118–125. PubMed:22101257doi:10.1016/j.yexmp.2011.10.011ISSN 1096-0945Artikkelin verkkoversio.
Natalie Kash, Michael A. Lee, Ramya Kollipara, Christopher Downing, Jacqueline Guidry, Stephen K. Tyring: Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus. Journal of Clinical Medicine, 3.4.2015, 4. vsk, nro 4, s. 614–633. PubMed:26239350doi:10.3390/jcm4040614ISSN 2077-0383Artikkelin verkkoversio.
Jeffrey D Stanaway, Abraham D Flaxman, Mohsen Naghavi, Christina Fitzmaurice, Theo Vos, Ibrahim Abubakar: The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet, 10.9.2016, 388. vsk, nro 10049, s. 1081–1088. PubMed:27394647doi:10.1016/S0140-6736(16)30579-7ISSN 0140-6736Artikkelin verkkoversio.
Centers for Disease Control and Prevention (CDC): FDA approval for a combined hepatitis A and B vaccine. Morbidity and mortality weekly report, 21.9.2001, 50. vsk, nro 37, s. 806–807. PubMed:11785573ISSN 0149-2195Artikkelin verkkoversio.
Jianming Hu, Laurie Ludgate: HIV-HBV and HIV-HCV coinfection and liver cancer development. Cancer Treatment and Research, 2007, nro 133, s. 241–252. PubMed:17672044ISSN 0927-3042
Ryan J. Sullivan, Liron Pantanowitz, Corey Casper, Justin Stebbing, Bruce J. Dezube: Epidemiology, pathophysiology and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clinical infectious diseases, 1.11.2008, 47. vsk, nro 9, s. 1209–1215. PubMed:18808357doi:10.1086/592298ISSN 1058-4838Artikkelin verkkoversio.
Marcia Bellon, Christophe Nicot: Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia. Cancer Genomics & Proteomics, tammikuu 2007, 4. vsk, nro 1, s. 21–25. PubMed:17726237ISSN 1109-6535Artikkelin verkkoversio.
Michael Melnick, Parish P. Sedghizadeh, Carl M. Allen, Tina Jaskoll: Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Experimental and Molecular Pathology, helmikuu 2012, 92. vsk, nro 1, s. 118–125. PubMed:22101257doi:10.1016/j.yexmp.2011.10.011ISSN 1096-0945Artikkelin verkkoversio.